Association between immune-associated disorders and adverse outcomes of ileal pouch-anal anastomosis

American Journal of Gastroenterology

Volumn 104, Issue 3, 2009, Pages 655-664

  Shen, Bo ^a   Remzi, Feza H ^a   Nutter, Benjamin ^a   Bennett, Ana E ^a   Lashner, Bret A ^a   Lavery, Ian C ^a   Brzezinski, Aaron ^a   Bambrick, Marlene L ^a   Queener, Elaine ^a   Fazio, Victor W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CORTICOSTEROID; IMMUNOMODULATING AGENT; MESALAZINE; METRONIDAZOLE;

ADULT; ADVERSE OUTCOME; AGED; ANASTOMOSIS; ANTIBIOTIC THERAPY; ARTICLE; AUTOIMMUNE DISEASE; CHRONIC ANTIBIOTIC REFRACTORY POUCHITIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HAZARD RATIO; HOSPITALIZATION; HUMAN; ILEITIS; ILEOANAL ANASTOMOSIS; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; PROCTOCOLECTOMY; RISK ASSESSMENT;

ADULT; AUTOIMMUNE DISEASES; COLONIC POUCHES; CROHN DISEASE; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; POUCHITIS; PROPORTIONAL HAZARDS MODELS; REOPERATION;

EID: 61949398029     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2008.76     Document Type: Article

References (44)

1. Sandborn W. Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 1994;107:1856-60.
2. Gosselink MP, Schouten WR, van Lieshout LMC et al. Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG. Dis Colon Rectum 2004;47:876-84.
3. Gionchetti P, Rizzello F, Venturi A et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000;119:305-9.
4. Mimura T, Rizzello F, Helwig U et al. Once daily high dose probiotic therapy (VSL#3®) for maintaining remission in recurrent or refractory pouchitis. Gut 2004;53:108-14.
5. Komanduri S, Gillevet PM, Sikaroodi M et al. Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation. Clin Gastroenterol Hepatol 2007;5:352-60.
6. Duffy M, O'Mahony L, Coffey JC et al. Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis. Dis Colon Rectum 2002;45:384-8.
7. Nasmyth DG, Godwin PGR, Dixon MF et al. Ileal ecology after pouch anal anastomosis or ileostomy. Gastroenterology 1989;96:817-24.
8. Komanduri S, Gillevet PM, Sikaroodi M et al. Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation. Clin Gastroenterol Hepatol 2007;5:352-60.
9. Weng X, Liu L, Barcellos LF et al. Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern California-managed care organization. Am J Gastroenterol 2007;102:1429-35.
10. Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 2005;129:827-36.
11. Barcellos LF, Kamdar BB, Ramsay PP et al. Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study. Lancet Neurol 2006;5:924-31.
12. Shen B, Remzi FH, Lavery IC et al. A proposed classification of ileal pouch disorders and associated complications after restorative proctocolectomy. Clin Gastroenterol Hepatol 2008;6:145-58.
13. Sandborn WJ, Tremaine WJ, Batts KP et al. Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index. Mayo Clin Proc 1994;69:409-15.
14. Shen B, Lashner BA, Achkar J-P et al. Modified pouchitis disease activity index: a simplified approach to the diagnosis of pouchitis. Dis Colon Rectum 2003;46:748-53.
15. Shen B, Fazio VW, Remzi FH et al. Risk factors for diseases of ileal pouch-anal anastomosis in patients with ulcerative colitis. Clin Gastroenterol Hepatol 2006;4:81-9.
16. Ricart E, Panaccione R, Loftus EV Jr et al. Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study. Inflamm Bowel Dis 2004;10:207-14.
17. Penna C, Dozois R, Tremaine W et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996;38:234-9.
18. Okon A, Dubinsky M, Vasilauskas EA et al. Elevated Platelet count before ileal pouch-anal anastomosis for ulcerative colitis is associated with the development of chronic pouchitis. Am Surg 2005;71:821-6.
19. Fleshner P, Ippoliti A, Dubinsky M et al. A prospective multivariate analysis of clinical factors associated with pouchitis after ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2007;5:952-8.
20. Shepherd NA, Hulten L, Tytgat GNJ. Workshop: pouchitis. Int J Colorectal Dis 1989;4:205-29.
21. Lohmuller JL, Pemberton HJ, Dozois RR et al. Pouchitis and extraintestinal manifestations of in ammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 1990;211:622-9.
22. Hata K, Watanabe T, Shinozaki M et al. Patients with extraintestinal manifestations have a higher risk of developing pouchitis in ulcerative colitis: multivariate analysis. Scand J Gastroenterol 2003;38:1055-8.
23. Fleshner P, Ippoliti A, Dubinsky M et al. Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2008;6:561-8.
24. Shen B, Fazio VW, Remzi FH et al. Clinical approaches to ileal pouch diseases. Am J Gastroenterol 2005;100:2796-807.
25. Chaussade S, Denizot Y, Valleur P et al. Presence of PAF-acether in stool of patients with pouch ileoanal anastomosis and pouchitis. Gastroenterology 1991;100:419-23.
26. Shepherd NA, Healey CJ, Warren BF et al. Distribution of mucosal morphology and an assessment of colonic phenotype change in the pelvic ileal reservoir. Gut 1993;34:101-5.
27. Biancone L, Palmieri G, Lombardi A et al. Tropomyosin expression in the ileal pouch: a relationship with the development of pouchitis in ulcerative colitis. Am J Gastroenterol 2003;98:2719-26.
28. Tysk C, Riedesel H, Lindberg E et al. Colonic glycoproteins in monozygote twins with inflammatory bowel disease. Gastroenterology 1991;100:1509-14.
29. Merrett MN, Soper N, Mortensen N et al. Intestinal permeability in the ileal pouch. Gut 1996;39:226-30.
30. Lohmuller JL, Pemberton HJ, Dozois RR et al. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 1990;211:622-9.
31. Merrett MN, Mortensen N, Kettlewell M et al. Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis. Gut 1996;38:362-4.
32. DeSilva HJ, Jones M, Prince C et al. Lymphocyte and macrophage subpopulations in pelvic ileal reservoirs. Gut 1991;32:1160-5.
33. Hirata I, Berrebi G, Austin LL et al. Immunohistologi cal characterization of intraepithelial and lamina propria lymphocytes in control ileum and colon and inflammatory bowel disease. Dig Dis Sci 1986;31:593-603.
34. Stallmach A, Schafer F, Hoffman S et al. Increased state of activation of CD4 positive T cells and elevated interferon gamma production in pouchitis. Gut 1998;43:499-505.
35. Thomas PD, Forbes A, Nicholls RJ et al. Altered expression of the lymphocyte activation markers CD30 and CD27 in patients with pouchitis. Scand J Gastroenterol 2001;36:258-64.
36. Goldberg PA, Herbst F, Beckett CG et al. Leukocyte typing, cytokine expression and epithelial turn over in the ileal pouch in patients with ulcerative colitis and familial adenomatous polyposis. Gut 1996;38:549-53.
37. P atel RT, Bain I, Y oungs D et al. Cytokine production in pouchitis is similar to that in ulcerative colitis. Dis Colon Rectum 1995;38:831-7.
38. Schmidt C, Giese T, Ludwig B et al. Increased cytokine transcripts in pouchitis reflect the degree of inflammation but not the underlying entity. Int J Colorectal Dis 2006;21:419-26.
39. Gionchetti P, Campieri M, Belluzzi A et al. Mucosal concentrations of interleukin-1β, interleukin-6, interleukin-8, and tumor necrosis factor-α in pelvic ileal pouches. Dig Dis Sci 1994;39:1525-31.
40. Patel RT, Pall AA, Adu D et al. Circulating soluble adhesion molecules in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995;7:1037-41.
41. Chaussade S, Denizot Y, Valleur P et al. Presence of PAF-acether in stool of patients with pouch ileoanal anastomosis and pouchitis. Gastroenterology 1991;100:419-23.
42. Gertner DJ, Rampton DS, Madden MV et al. Increased leukotriene B4 release from ileal pouch mucosa in ulcerative colitis compared with familial adenomatous polyposis. Gut 1994;35:1429-32.
43. Stallmach A, Chan CC, Ecker K-W et al. Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis. Gut 2000;47:415-22.
44. Shen B, Jiang Z-D, F azio VW et al. Clostridium diffcile infection in patients with ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2008;6:62-8.